Valosin-Containing Protein Phosphorylation at Ser784 in Response to DNA Damage
Mark Livingstone(Institut Pasteur), Thanos D. Halazonetis(University of Geneva), Katarina Moravcevic(The Wistar Institute), Vassilis G. Gorgoulis(National and Kapodistrian University of Athens), Richard A. DiTullio(The Wistar Institute), James M. Gardner(University of California, San Francisco), Tamara A. Mochan(The Wistar Institute), Peter R. Strack(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jessica Weiner(Millennium Engineering and Integration (United States)), Amy J. Williams(University of Florida), Monica Venere(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Hong Ruan(Shanghai Jiao Tong University), Shengfang Jin(Agios Pharmaceuticals (United States)), Heidi Greulich(Broad Institute), Anne L. Burkhardt(Millennium Engineering and Integration (United States)), Karl R. Clauser(Broad Institute)
Cited by 71
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Cellular Senescence: Defining a Path Forward
|Cell|2019|3k
Somatic mutations affect key pathways in lung adenocarcinoma
|Nature|2008|2.8k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996